EUVIMEDEUVIMED entdecken
Open Access

Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation

Bivek Chaulagain iD, Jagdish Singh iD

Molecular Pharmaceutics · 06.01.2025 · 22 (1) · 154-167

DOI: 10.1021/acs.molpharmaceut.4c00811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.11.2024. Verfasst von Bivek Chaulagain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 5…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Nanoparticles, Cannabidiol, Mannose. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is emerging as a critical player in the disease progression of Alzheimer's disease (AD) by its interaction with amyloid beta plaques in a feed-forward loop. There is also a decline in the nourishment and enriching neurotrophic factor, brain-derived neurotrophic factor (BDNF), in the brain. Therefore, supplementing the brain with BDNF by gene delivery and delivering the anti-inflammatory agent, cannabidiol (CBD) in this case, to mitigate inflammation-induced disease cascade offers an attractive treatment strategy. To achieve the brain localization of CBD and pBDNF, lipid nanoparticles (LNPs) functionalized with mannose and penetratin were utilized. CBD and pBDNF were successfully encapsulated in the LNPs (more than 80%) with a size less than 180 nm, polydispersity index less than 0.25, and zeta potential of 23 mV. CBD was released from the formulation over a period of a week. The dual-functionalized LNPs demonstrated higher cellular uptake of CBD and expressed a significantly higher amount of BDNF (p-value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorNanoparticlesCannabidiolMannoseAmyloid beta-PeptidesInflammationAlzheimer DiseaseHumansAnimalsCell-Penetrating PeptidesLipidsCell LineMiceBrainMicrogliaGene Transfer TechniquesBlood-Brain BarrierLiposomes

Stichwörter der Autor:innen

Alzheimer’s disease (AD)BDNFCannabidiol (CBD)amyloidinflammation

Substanzen

Brain-Derived Neurotrophic FactorCannabidiolMannoseAmyloid beta-PeptidesCell-Penetrating PeptidesLipidsLipid NanoparticlesBDNF protein, humanLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 58105, United States.

ORCID-Profile: Bivek Chaulagain, Jagdish Singh

Förderung

  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Chaulagain, B., & Singh, J. (2025). Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation. Molecular Pharmaceutics, 22(1), 154-167. https://doi.org/10.1021/acs.molpharmaceut.4c00811

Vancouver

Chaulagain B, Singh J. Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation. Molecular Pharmaceutics. 2025;22(1):154-167. doi:10.1021/acs.molpharmaceut.4c00811

BibTeX
@article{Chaulagain2025,
  author = {Chaulagain, Bivek and Singh, Jagdish},
  title = {Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {1},
  pages = {154--167},
  doi = {10.1021/acs.molpharmaceut.4c00811}
}
Kostenlos starten →